BiotechTube
Home/Sinntaxis/Tadeusz Wieloch
TW

Tadeusz Wieloch

CEO, Founder

Sinntaxis

Therapeutic Areas

NeurologyStroke

Sinntaxis Pipeline

DrugIndicationPhase
mGluR5 NAM for Stroke Recovery (dipraglurant via Addex)Recovery of brain function after stroke/brain injuryPhase 2 Ready

Leadership Team at Sinntaxis

CW
Christine Widstrand
Chairman of the Board
LÖ
Lars Öhman
Board Member
View full Sinntaxis profile